Navigation Links
Pharmaceutical Investment & Cost Benchmarks Accessed Quickly Through Best Practices, LLC's New Database Search Function

CHAPEL HILL, N.C., Nov. 16, 2011 /PRNewswire/ -- Savvy executives in pharmaceutical commercial functions examine investment and cost benchmarks to remain competitive in today's volatile healthcare environment. Quantitative and qualitative investment benchmarking data can support a business case for increased resources, justify costs, or signal necessary course changes.

To support pharmaceutical vice presidents, directors, and managers tasked with right-sizing investment levels and justifying costs, Best Practices, LLC launches Investment & Cost Benchmark Analyzer within the Wizards & Analytics Search ( The new Wizard searches the Best Practice Database for investment and cost benchmarks on a specified function, group, or business issue, such as pharmaceutical new product launch.

How to Effectively Use the Investment & Cost Benchmark Analyzer:

  • Visit the Investment & Cost Benchmark Analyzer at  
  • In the second text box, insert the pharmaceutical business issue of "product launch" in quotations.
  • Click the "Search Now" button to the right of the text box.
  • Review the list of relevant documents in the Best Practice Database.
  • Click on the document titles of most interest, including the first hit "Winning in the U.S. Marketplace: Pre-launch and Launch Investment Benchmarks for New Products." (

Best Practice Database documents include benchmarks and insights gathered from quantitative and qualitative primary research with executives at pharmaceutical companies. Subscribers to the Best Practice Database have access to these primary research results to make informed decisions in their functional areas. Within the documents, charts, graphs, and process maps enable executives to assess resource levels, responsibility scope, and performance metrics of their function.

For more information on the Investment & Cost Benchmark Analyzer or how to determine if your group is among the low performers or the best-in-class performers, contact us at 919.403.0251 or at    

BEST PRACTICES, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide.

Best Practices, LLC's clients include the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our reports, database, and advisory services to support executives in commercial and R&D operations.

Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Idenix Pharmaceuticals Announces Proposed Public Offering of Common Stock
2. Radient Pharmaceuticals Asks DHS Holding Co. to Retract News Release Saying It Will Enter Into Talks With Radient Pharmaceuticals Corporation
3. The Outlook for Pharmaceuticals in South East Asia
4. The Outlook for Pharmaceuticals in Western Europe
5. The Outlook for Pharmaceuticals in Central & Eastern Europe
6. The Outlook for Pharmaceuticals in the Middle East and North Africa
7. The Outlook for Pharmaceuticals in Brazil, Russia, India & China
8. The Outlook for Pharmaceuticals in Latin America
9. Bristol-Myers Squibb: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
10. Sustainability in the Global Pharmaceutical Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Pharmaceutical Industry Procurement and Marketing Initiatives
11. Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Post Your Comments:
(Date:10/12/2015)... New York , October 12, 2015 ... (FMI) delivers key insights on the global vital signs monitoring ... Devices Market: Global Industry Analysis and Opportunity Assessment 2015-2025." The ... at a healthy CAGR of 9.5% and 9.2% in terms ... to factors, regarding which FMI offers major insights in detail ...
(Date:10/12/2015)... Oct. 12, 2015 Beginning October 1, 2015 ... Partner, the fastest growing practice management system for therapists, ... easily converts all patient diagnostic codes from the former ... --> --> Therapy Partner has ... mental health practitioners to easily understand the conversion to ...
(Date:10/12/2015)... , Oct. 12, 2015 Indivior PLC (LON: INDV) ... of Delaware granted the Company,s motion ... Abbreviated New Drug Application (ANDA) No. 205299 to market a ... and naloxone) Sublingual Film (CIII) in the United ... Since August 2013, Indivior has received Paragraph IV certifications ...
Breaking Medicine Technology:
(Date:10/12/2015)... ... October 12, 2015 , ... To help ... its charitable donation to the National Breast Cancer Foundation. The National Breast Cancer ... breast cancer through early detection, education, and support services. , The annual campaign ...
(Date:10/12/2015)... ... October 12, 2015 , ... SQM Group ... a contact channel benchmarking study. Be a part of this insightful ... for improving customer experience, customer journey, contact channel execution and intelligence, workforce optimization, ...
(Date:10/12/2015)... ... ... Holcomb – Kreithen Plastic Surgery and MedSpa, PLLC (“Holcomb – Kreithen”), one of ... Surgery University,” an educational series of mini seminars covering aesthetic and plastic surgery options, ... Saturday, October 24, 2015. , The goal of the event is to provide hands-on ...
(Date:10/12/2015)... ... October 12, 2015 , ... The Asthma and ... Engagement Award by the Patient-Centered Outcomes Research Institute (PCORI) for a new project ... , The project, entitled “Training Patients with Asthma to Understand and Participate in ...
(Date:10/12/2015)... ... October 12, 2015 , ... International law firm Greenberg ... with the U.S. Biomedical Advanced Research and Development Authority (BARDA) reported to be ... ReCell® Autologous Cell Harvesting Device under a U.S. mass casualty preparedness program. ...
Breaking Medicine News(10 mins):